Preclinical in vitro and in vivo activity of trastuzumab deruxtecan against <em>ERBB2</em>-mutated cervical carcinomas with low HER2 expression
Listen to this summary
The authors investigate the efficacy of trastuzumab deruxtecan (T-DXd) as a targeted therapy for cervical carcinomas with somatic HER2 mutations, specifically focusing on those with low HER2 expression. Their findings demonstrate that T-DXd significantly outperforms control treatments in both in vitro and in vivo models of HER2-S310F-mutated cervical cancer, suggesting it could be a promising therapeutic option for patients with recurrent cervical cancer harboring ERBB2 mutations.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Gynecologic oncology reports
View all →Aug 8, 2026 · Gynecologic oncology reports
Rescuing a refractory Leiomyosarcoma: ALK-DCTN1 fusion as a gateway to long-term control with Ceritinib
Aug 8, 2026 · Gynecologic oncology reports
Interval debulking with HIPEC in patient with VP shunt
Aug 5, 2026 · Gynecologic oncology reports
Primary ovarian synovial sarcoma in an adolescent mimicking a germ cell tumor: A case report and diagnostic challenge
Jul 28, 2026 · Gynecologic oncology reports
Malignant transformation of mature ovarian teratoma into goblet cell adenocarcinoma: a case report
Jul 28, 2026 · Gynecologic oncology reports
Quality of life and psychological outcomes with albumin-bound paclitaxel-carboplatin versus solvent-based paclitaxel-carboplatin as first-line chemotherapy in stage IC-IV ovarian carcinoma
Jul 26, 2026 · Gynecologic oncology reports
Leading the way: A national mixed-methods survey of race, ethnicity, and gender among gynecologic oncology leaders at ACGME-accredited fellowship programs
More in Obstetrics & Gynecology
View all →Aug 9, 2026 · Journal of minimally invasive gynecology
Letter to the Editor Regarding "Bowel Injuries Reported After NovaSure Endometrial Ablation: A 10-Year Review of FDA MAUDE Data." Title: "Bowel Injury Following Endometrial Ablation: A Plausible Mechanism and Prevention Strategy."
Aug 9, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
High-Frequency Ultrasound Assessment of Female Genital Rejuvenation
Aug 9, 2026 · Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine
From ACR O-RADS 2022 to Explainable Deep Learning: Comparative Performance of Expert Radiologists, Convolutional Neural Networks, Vision Transformers, and Fusion Models for Ultrasound-Based Risk Stratification of Ovarian Masses
Aug 9, 2026 · Human reproduction (Oxford, England)
Preconception 1-hour blood glucose as an early indicator of gestational diabetes mellitus risk in PMOS/PCOS women undergoing IVF treatment: a multi-centre cohort study
Aug 9, 2026 · Journal of minimally invasive gynecology
Beyond the Mass Effect: Decoupling Endometrioma Size and Bilaterality from Ovarian Reserve Depletion
Aug 8, 2026 · Gynecologic oncology
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


